These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 27696724

  • 1. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME, Hsia E, Aletaha D.
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [Abstract] [Full Text] [Related]

  • 2. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
    Rintelen B, Sautner J, Haindl P, Mai H, Brezinschek HP, Leeb BF.
    J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y, Kondo H, Takeuchi T.
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y, Smolen JS, Jones H, Szumski A, Marshall L, Emery P.
    Arthritis Res Ther; 2019 Jul 05; 21(1):164. PubMed ID: 31277720
    [Abstract] [Full Text] [Related]

  • 10. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.
    Arthritis Rheum; 2012 May 05; 64(5):1316-22. PubMed ID: 22135142
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey.
    Wang GY, Zhang SL, Wang XR, Feng M, Li C, An Y, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Yan HM, Wang GC, Lu X, Liu X, Zhu P, Chen LN, Jin HT, Liu JT, Guo HF, Chen HY, Xie JL, Wei P, Wang JX, Liu XY, Sun L, Cui LF, Shu R, Liu BL, Yu P, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Han SL, Yang XY, Li H, Huang CB, Gao M, Lai B, Cheng YJ, Li XF, Song LJ, Yu XX, Wang AX, Wu LJ, Wang YH, He L, Sun WW, Gong L, Wang XY, Wang Y, Zhao Y, Li XX, Wang Y, Zhang Y, Su Y, Zhang CF, Mu R, Li ZG.
    Clin Rheumatol; 2015 Feb 05; 34(2):221-30. PubMed ID: 25413735
    [Abstract] [Full Text] [Related]

  • 16. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.
    Ann Rheum Dis; 2011 Oct 05; 70(10):1815-21. PubMed ID: 21813548
    [Abstract] [Full Text] [Related]

  • 17. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
    Smolen JS, Wollenhaupt J, Gomez-Reino JJ, Grassi W, Gaillez C, Poncet C, Le Bars M, Westhovens R.
    Arthritis Res Ther; 2015 Jun 11; 17(1):157. PubMed ID: 26063454
    [Abstract] [Full Text] [Related]

  • 18. A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.
    Yoo DH, Racewicz A, Brzezicki J, Yatsyshyn R, Arteaga ET, Baranauskaite A, Abud-Mendoza C, Navarra S, Kadinov V, Sariego IG, Hong SS, Lee SY, Park W.
    Arthritis Res Ther; 2016 Apr 02; 18():82. PubMed ID: 27038608
    [Abstract] [Full Text] [Related]

  • 19. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision.
    Studenic P, Aletaha D, de Wit M, Stamm TA, Alasti F, Lacaille D, Smolen JS, Felson DT.
    Ann Rheum Dis; 2023 Jan 02; 82(1):74-80. PubMed ID: 36280238
    [Abstract] [Full Text] [Related]

  • 20. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.
    Studenic P, Aletaha D, de Wit M, Stamm TA, Alasti F, Lacaille D, Smolen JS, Felson DT.
    Arthritis Rheumatol; 2023 Jan 02; 75(1):15-22. PubMed ID: 36274193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.